COMP <GO>
ALGN vs UNH // ENTERPRISE SCALE & MARKET CAP
Align Technology Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: ALGN 5
— UNH 9
▲ ENTERPRISE SCALE & MARKET CAP LEADER: UNH
LAST: $149.89 (-2.49%) • MKT CAP: $10.92B
market-cap
$10.92B
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
market-cap
$364.66B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ALGN VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ALGN | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 67.20% | 88.57% | -21.37 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.10% | 11.47% | -0.37 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 17.0x | 16.4x | +0.55 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 4.49% | 6.48% | -1.99 | UNH | /fcf-yield <GO> |
| Operating Margin | 13.50% | 4.82% | +8.68 | ALGN | /operating-margins <GO> |
| Net Profit Margin | 10.20% | 3.14% | +7.06 | ALGN | /net-margins <GO> |
| Revenue Growth (YoY) | 0.90% | 6.46% | -5.56 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.62 | 3.12 | +1.50 | ALGN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 6.74% | -0.14 | ALGN | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.8 | 56.0 | -6.24 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.90 | 0.33 | +0.57 | ALGN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 24.7x | 17.1x | +7.61 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $10.92B | $364.66B | -$353.74B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ALGN REV | UNH REV | ALGN GROSS % | UNH GROSS % | ALGN FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.03B | $447.57B | 67.2% | 88.7% | $490.8M | $16.07B |
| FY 2024 | $4.00B | $400.28B | 70.0% | 88.3% | $622.7M | $20.70B |
| FY 2023 | $3.86B | $371.62B | 44.0% | 89.6% | $612.0M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ALGN // BETA 0.90
UNH // BETA 0.33